03.12.2012
Anne Corcoran

Nuclear Dynamics Programme Babraham Institute, Cambridge, United Kingdom

“Non-coding RNA transcription and nuclear organisation play key roles in immunoglobulin Recombination”

 

29.10.2012
Michael White

University of Texas, UT Southwestern Medical Center, United States

“Oncogenome - selective vulnerabilities in lung adenocarcinoma”

 

15.10.2012
Christoph Plass

Department of Epigenomics and Cancer Risk Factors, German Cancer Research Center in the Helmholtz Association, Germany

“Global epigenetic alterations in chronic lymphocytic leukemia”

 

08.10.2012
Paul Flicek 

EMBL Outstation - Hinxton, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

“Comparative regulatory genomics provides insight into the evolution of transcriptional regulation”

 

01.10.2012
Matthias Mann

Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Germany

“Comprehensive proteome analysis and some of its applications”

 

23.07.2012
Andrew MCKenzie

MRC Laboratory of Molecular Biology, Cambridge, United Kingdom

“Type-2 innate lymphoid cells in protective immunity and asthma“

 

25.06.2012
Michael Hemann

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), United States

“Using mouse models to identify new cancer drug targets”

 

18.06.2012
Garret A. FitzGerald

Department of Pharmacology, Institute for Translational Medicine & Therapeutics (ITMAT), Perelman School of Medicine, University of Pennsylvania, United States 

“Peripheral Clocks in Cardiometabolic Function”

 

04.06.2012
Maria Sibilia

Institute for Cancer Research, Dept. of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Austria

“Defining the functions of EGFR in Cancer and beyond”

 

21.05.2012
Amos Bairoch

Director of Structural Biology and Bioinformatics Department, Swiss Institute of Bioinformatics, University of Geneva, Switzerland

“The CALIPHO group: neXtProt, a new knowledge platform on human proteins and on-going work toward the characterization of some human proteins”

 

14.05.2012
Michael J. Eck

Department of Cancer Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States

“TKinase Targets in Lung Cancer: Structure, mechanism and inhibition of EGFR and TBK1”

 

07.05.2012 
Claus Nerlov 

MRC Centre for Regenerative Medicine SCRM Building, The University of Edinburgh, Scotland

“Identification of novel pathways & mechanisms of hematopoitic lineage specification”

 

23.04.2012
Philippe Sansonetti 

INSERM U786 “Unité de Pathogénie Microbienne Moléculaire”, Institut Pasteur, Paris, France

“Unité de Pathogénie Microbienne Moléculaire”

 

16.04.2012
Forest White 

Department of Biological Engineering, Massachusetts Institute of Technology (MIT) and Koch Institute for Integrative Cancer Research, USA

“Using Quantitative Proteomics to Connect Genotype to Phenotype”

 

02.04.2012
Julie Magarian Blander

Immunology Institute, Mount Sinai Medical Center, New York, United States

“Vita-PAMPs: Signatures of Microbial Viability”

 

26.03.2012
Jean-Laurent Casanova

St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University, United States

“Toward a genetic theory of infectious diseases”

 

12.03.2012
Laurence Calzone & Emmanuel Barillot 

Computational Systems Biology of Cancer, Institute Curie, Paris, France

“A Systems Biology Approach for modeling signalling network involved in Cancer”

 

05.03.2012 
Kai Johnson

Institute of Chemical Sciences & Engineering, École Polytechnique Fédérale de Lausanne, Switzerland

“Spying on drugs and metabolites in living cells”

 

27.02.2012
Axel Behrens 

CR-UK London Research Institute, United Kingdom

“Stress and DNA damage signalling in stem cells and cancer” 

 

20.02.2012 
Magnus Nordborg 

Gregor Mendel Institute of Molecular Plant Biology (GMI), Vienna, Austria

“Investigating the genotype-phenotype map using Arabidopsis”

 

13.02.2012 
Bodo Grimbacher 

Research group “Experimental Immunodeficiency“, Centre of Chronic Immunodeficiency, Freiburg, Germany

“A novel monogenetic defect causing autoimmunity and hypogammaglobulinemia”

 

06.02.2012
Kristian Helin 

Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Denmark

“Functional Roles of TET proteins and Hydroxymethylation in Stem Cells and Cancer”

 

30.01.2012
Meinrad Busslinger 

The Research Institute of Molecular Pathology (IMP), Vienna, Austria

“Lineage commitment and plasticity of B lymphocytes”